Urinary IgG is a pure strong indicator of diabetic nephropathy than microalbuminuria in type 2 diabetic patients

International Journal of Diabetes in Developing Countries

Volumn 33, Issue 1, 2013, Pages 46-54

  Mohan, Sandesh ^a   Kalia, Kiran ^a   Mannari, Jyoti ^b  

^a SARDAR PATEL UNIVERSITY   (India)

^b M S Patel Cancer Centre Shree Krishna Hospital and Medical Research Centre   (India)

Author keywords

Diabetic microvascular and macrovascular complications; eGFR: estimated Glomerular Filtration Rate; Urinary albumin; Urinary Immunoglobulin G

Indexed keywords

EID: 84873467272     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.1007/s13410-012-0104-0     Document Type: Article

References (42)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
2. Keigher C, Avalos G, Dunne F. Treating to target in type 2 diabetes. Br J Diabetes Vasc Dis. 2007;7:83-5. (Pubitemid 46779540)
3. Voulgari C, Papadogiannis D, Tentolouris N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag. 2010;6:883-903.
4. Shabrawey MA, Smith S. Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers. EPMA J. 2010;1:56-72.
5. Klein R, Klein BE, Linton KL, Moss SE. Microalbuminuria in a population-based study of diabetes. Arch Intern Med. 1992;152:153-8.
6. Maskari FA, Sadig ME, Obineche E. Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates. BMC Nephrol. 2008;9:1-9. (Pubitemid 351432872)
7. Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol. 2007;2:581-90.
8. Gall MA, Rossing P, Skott P, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1991;34:655-61.
9. Manaviat MR, Afkhami M, Shoja MR. Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmol. 2004;4:1-4. (Pubitemid 39258904)
10. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet. 1988;2:530-3.
11. Mattock MB, Keen H, Viberti GC, et al. Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1988;31:82-7. (Pubitemid 18095543)
12. Kroll MH, Chesler R, Hagengruber C, Blank DW, Kestner J, Rawe M. Automated determination of urinary creatinine without sample dilution: theory and practice. Clin Chem. 1986;32:446-52. (Pubitemid 17016958)
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
14. Chandalia HB, Sadikot S, Bhargav DK, Krishnaswamy PR. Estimation of glycosylated hemoglobins by a simple chemical method and its use in monitoring control of diabetes mellitus. J Assoc Physicians India. 1980;28:285-6.
15. Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972;47:389-94.
16. Kakkar P, Das B, Vishwanathan PN. A modified spectrophtometeric assay of superoxide dismutase. Indian J Biochem Biophys. 1984;21:130-2. (Pubitemid 15207169)
17. Flohe L, Gunzler WA. Assay of glutathione peroxidase. Methods Enzymol. 1984;105:114-21.
18. Charlton-Menys V, Liu Y, Durrington NP. Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrate. Clin Chem. 2006;52:453-7.
19. Mallikarjunappa S, Prakash M. Urine protein thiol in chronic renal failiour patients. Indian J Nephrol. 2007;17:7-9.
20. Benzin FFI, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "Antioxident Power": the FRAP assay. Anal Biochem. 1996;239:70-6. (Pubitemid 26256285)
21. Mistry K, Kalia K. Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy. Indian J Clin Biochem. 2008;23:159-65.
22. Singh NP, Ingle GK, Saini VK, Jami A, Beniwal P, Lal M, Meena GS. Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in north India using Cockcroft-Gault and modification of diet in renal disease equation: an observational, cross-sectional study. BMC Nephrol. 2009;10:1-13.
23. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease. Circulation. 2003;108:2154-69. (Pubitemid 37337595)
24. Bash LD, Coresh J, Kottgen A, Parekh RS, Fulop T, Wang Y, Astor BC. Defining incident chronic kidney disease in the research setting. Am J Epidemiol. 2009;170:414-24.
25. Romero P, Baget M, Mendez I, Fernandez J, Salvat M, Martinez I. Diabetic macular edema and its relationship to renal microangiopathy: a sample of type I diabetes mellitus patients in a 15-year follow-up study. J Diabetes Complications. 2007;21:172-80. (Pubitemid 46711079)
26. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Progression of diabetic nephropathy. Kidney Int. 2001;59:702-9. (Pubitemid 32157935)
27. Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med. 2003;35:1491-9. (Pubitemid 37452474)
28. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26:77-82. (Pubitemid 351556223)
29. Deckert T, Kofoe-Enevoldsen A, Vidal P, Norgaard K, Andreasen HB, Feldt-Rasmussen B. Size and charge selectivity of glomerular filtration in type 1 (insulin dependent) diabetic patients with and without albuminuria. Diabetologia. 1993;36:244-51. (Pubitemid 23067087)
30. Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia. 2008;51:714-25.
31. Christensen PK, Larsen S, Horn T, Olsen S, Parving HH. Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int. 2000;58:1719-31.
32. Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res. 1996;79:581-9. (Pubitemid 26276918)
33. Thorner PS, Ho M, Eremina V, Sado Y, Quaggin S. Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol. 2008;19:495-502. (Pubitemid 351355393)
34. Lewis EJ, Xu X. Abnormal glomerular permeability characteristics in diabetic nephropathy. Diabetes Care. 2008;31:S202-7.
35. Singh A, Satchell SC, Neal CR, McKenzie EA, Tooke JE, Mathieson PW. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol. 2007;18:2885-93. (Pubitemid 350058395)
36. Verzola D, Bandolfo MT, Ferrario F, Rastaldi MP, Villaggio B, Gianiorio F, et al. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int. 2007;72:1262-72. (Pubitemid 350059668)
37. Weng CH, Hu CC, Yu CC, Lin JL, Yang CW, Hung CC, et al. Immunoglobulin G levels can predict non-diabetic renal disease in patients with type 2 diabetes mellitus. J Diabetes. 2012;4:37-40.
38. Mohan S, Kalia K, Mannari J. Diabetic nephropathy and associated risk factors for renal deterioration. Int J Diabetes Dev Ctries. 2011. doi: 10.1007/s13410-011-0047-x.
39. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJP, Stroes ES. The endothelial glycocalix: a potential barrier between health and vascular disease. Curr Opin Lipidol. 2005;16:507-11. (Pubitemid 41376899)
40. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-66.
41. Orea-Tejeda A, Colín-Ramírez E, Hernández-Gilsoul T, Castillo-Martínez L, Abasta-Jiménez M, Asensio-Lafuente E, David RN, Dorantes-García J. Microalbuminuria in systolic and diastolic chronic heart failure patients. Cardiol J. 2008;15:143-9. (Pubitemid 351721975)
42. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253-9. (Pubitemid 30068516)